Global Electrophysiology (EP) Device Market Growth 2025-2031
The global Electrophysiology (EP) Device market size is predicted to grow from US$ 6309 million in 2025 to US$ 8958 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Electrophysiology (EP) is the study of the mechanism, function and performance of electrical signaling pathways that guide the functioning of the heart. EP study is a procedure that is performed to diagnose arrhythmias by locating areas of heart tissue that interrupt the normal functioning of the heart"s electrical system. During an EP study, the electrophysiologist inserts several long, flexible tubes with wires, called catheters, into the heart to record electrical activity within the heart chambers and to detect abnormal electrical pathways. The second part of the test involves electrical stimulation of various parts of the heart to induce an abnormal heart rhythm. This helps the electro physiologist in treatment mapping, which could involve surgical removal of the abnormal tissue in the heart using a catheter.
The classification of Electrophysiology (EP) Device includes EP Ablation Catheters, EP Diagnostic Catheters, EP Mapping/Recording System, LAA and Other, and the revenue proportion of EP Ablation Catheters is about 31%, The EP Diagnostic Catheters is second major segment of Electrophysiology (EP) Device account for 16% of revenue share. And EP Mapping/Recording System account for 15% of revenue share.
Electrophysiology (EP) Device is widely sales in Atrial Fibrillation (AF) and Ventricular Tachycardia (VT). The most proportion of Electrophysiology (EP) Device is sales in Atrial Fibrillation (AF), and the consumption proportion is about 72%.
America is the largest consumption place, with a revenue market share nearly 43%. Following America, Europe is the second largest consumption place with the revenue market share of 29%, China is also an important sales region for the Electrophysiology (EP) Device.
Market competition is intense. Biosense Wester (J & J), Abbott, Medtronic and Boston Scientific are the leaders of the industry, with about 89% market shares.
LP Information, Inc. (LPI) ' newest research report, the “Electrophysiology (EP) Device Industry Forecast” looks at past sales and reviews total world Electrophysiology (EP) Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Electrophysiology (EP) Device sales for 2025 through 2031. With Electrophysiology (EP) Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Electrophysiology (EP) Device industry.
This Insight Report provides a comprehensive analysis of the global Electrophysiology (EP) Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Electrophysiology (EP) Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Electrophysiology (EP) Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Electrophysiology (EP) Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Electrophysiology (EP) Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Electrophysiology (EP) Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
EP Ablation Catheters
EP Diagnostic Catheters
EP Mapping/Recording System
LAA
Others
Segmentation by Application:
Atrial Fibrillation (AF)
Ventricular Tachycardia (VT)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Biosense Wester (J & J)
Abbott
Medtronic
Boston Scientific
AtriCure
GE Healthcare
MicroPort EP MedTech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Electrophysiology (EP) Device market?
What factors are driving Electrophysiology (EP) Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Electrophysiology (EP) Device market opportunities vary by end market size?
How does Electrophysiology (EP) Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.